首页> 外文OA文献 >Investigating the significance of coagulation kinetics on maintaining membrane permeability in an MBR following reactive coagulant dosing
【2h】

Investigating the significance of coagulation kinetics on maintaining membrane permeability in an MBR following reactive coagulant dosing

机译:研究凝结动力学对反应性凝结剂投加后维持MBR膜通透性的重要性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, the impact of kinetically controlled floc growth on sustaining membrane permeability following reactive coagulant dosing was determined using a model particle system. Floc formation was indicated to comprise of two stages following coagulant addition: (i) an initial destabilisation phase which encouraged complexation of protein and polysaccharide; and (ii) entrapment of the coarse model particles (3 µm Firefli™ microspheres) in the polymeric complex during the floc growth phase. Floc growth was characterised by an expected time lag as with conventional flocculation systems and biopolymer aggregation was kinetically favoured. When coagulant was dosed during the filtration cycle, the intermediate biopolymer aggregates (comprised of protein and polysaccharide) were preferentially transported toward the membrane increasing fouling. However, when coagulant was dosed at the onset of filtration, membrane fouling was constrained. It is asserted that by dosing at the onset of filtration: (i) early development of biopolymer aggregation is initiated which inhibits transport of the individual biopolymers to the membrane; and (ii) by dosing coagulant in the absence of a developed polarised layer, formation of biopolymer complexes local to the membrane is obviated. However, when dosing coagulant at the onset of filtration, only limited floc growth occurred which can be explained by the low applied wall shear rate and the absence of a ‘polarised’ region which ostensibly promoted floc growth when coagulant was dosed mid-filtration. Based on results from the model particle system studied, it is proposed that reactive coagulant dosing is best undertaken when: (i) filtration is stopped; (ii) modest shear is applied within the bioreactor to promote coagulant dispersion; and (iii) sufficient contact time is allowed to promote floc growth before commencement of filtration.
机译:在这项研究中,使用模型粒子系统确定了动态控制絮凝物生长对反应性混凝剂投加后维持膜通透性的影响。絮凝物的形成表明在添加凝结剂后包括两个阶段:(i)促进蛋白质和多糖复合的初始去稳定阶段; (ii)在絮状物生长阶段将粗模型颗粒(3 µm Firefli™微球)截留在聚合物复合物中。与常规絮凝系统一样,絮凝物的生长具有预期的时滞,并且在动力学上有利于生物聚合物的聚集。当在过滤周期中加入凝结剂时,中间生物聚合物聚集体(由蛋白质和多糖组成)优先向膜输送,增加了结垢。然而,当在过滤开始时加入凝结剂时,膜结垢受到限制。有人断言,通过在过滤开始时加药:(i)生物聚合物聚集的早期发展被启动,这抑制了单个生物聚合物向膜的运输; (ii)通过在不存在显影的偏振层的情况下计量凝结剂,避免了膜局部的生物聚合物复合物的形成。但是,在过滤开始时给混凝剂添加剂量时,仅发生有限的絮凝物生长,这可以解释为施加的壁剪切速率低,并且在混凝剂在过滤中加入剂量时,没有“极化”区域,表面上促进了絮凝物生长。根据所研究的模型粒子系统的结果,建议在以下情况下最好进行反应性混凝剂加料:(i)停止过滤; (ii)在生物反应器内施加适度的剪切力以促进凝结剂分散; (iii)在过滤开始前,有足够的接触时间以促进絮凝物的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号